239 related articles for article (PubMed ID: 20177966)
1. Adipocytokine resistin and breast cancer risk.
Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
[TBL] [Abstract][Full Text] [Related]
2. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
4. Measures of adiposity and risk of breast cancer in older postmenopausal women.
Krebs EE; Taylor BC; Cauley JA; Stone KL; Bowman PJ; Ensrud KE
J Am Geriatr Soc; 2006 Jan; 54(1):63-9. PubMed ID: 16420199
[TBL] [Abstract][Full Text] [Related]
5. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
6. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
7. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
8. Hyperresistinemia is associated with postmenopausal breast cancer.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
10. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
11. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
[TBL] [Abstract][Full Text] [Related]
12. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
15. Higher levels of central adiposity in healthy premenopausal women with family histories of premenopausal breast cancer.
Dettenborn L; James GD; Britton JA; Bovbjerg DH
Am J Hum Biol; 2008; 20(3):355-8. PubMed ID: 18161037
[TBL] [Abstract][Full Text] [Related]
16. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
17. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
[TBL] [Abstract][Full Text] [Related]
18. Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan.
Wu MH; Chu CH; Chou YC; Chou WY; Yang T; Hsu GC; Yu CP; Yu JC; Sun CA
Breast Cancer Res Treat; 2011 Jun; 127(3):777-84. PubMed ID: 21140205
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
20. Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
